| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/01/2000 | CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 03/01/2000 | CN1245808A Compound resisting hepatitis virus and its preparation method and its application in pharmaceutical technology |
| 02/29/2000 | US6031092 Preparation of phosphorothioate oligomers |
| 02/29/2000 | US6030996 Mur D inhibiting compounds, compositions containing such compounds and methods of use |
| 02/29/2000 | US6030957 Inhibiting hiv(human immunodeficiency virus) reverse transciptase in cells infected with hiv by administering to infected cells arylphosphate derivative of 2',3'-didehydro-2',3'-dideoxythymidine |
| 02/29/2000 | US6030776 Parallel SELEX |
| 02/29/2000 | CA2002648C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 02/24/2000 | WO2000009531A2 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B |
| 02/24/2000 | WO1999055857A3 Nucleoside triphosphates and their incorporation into ribozymes |
| 02/24/2000 | DE19837387A1 New nucleic acid analogs useful in therapeutic or diagnostic agents or electronic components, consist of 3'-deoxypentopyranosyl nucleosides |
| 02/24/2000 | CA2714085A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 02/24/2000 | CA2599597A1 .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/23/2000 | EP0980377A1 Anti-viral pyrimidine nucleoside analogues |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/22/2000 | US6028189 Solvent for oligonucleotide synthesis and methods of use |
| 02/22/2000 | US6028186 High affinity nucleic acid ligands of cytokines |
| 02/22/2000 | US6028183 Pyrimidine derivatives and oligonucleotides containing same |
| 02/22/2000 | US6028182 Methylphosphonic acid esters, processes for their preparation, and their use |
| 02/22/2000 | US6028097 Method of immunosuppression |
| 02/22/2000 | US6027885 Method for electrochemiluminescent labeling of nucleic acid, use in detection, and compositions therefor |
| 02/22/2000 | US6027709 Fluorescent cyanine dyes |
| 02/17/2000 | WO2000008042A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 02/17/2000 | WO2000008041A1 Structural analogs of amine bases and nucleosides |
| 02/17/2000 | WO2000008040A1 Sialyltransferase inhibitors |
| 02/17/2000 | CA2339408A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 02/16/2000 | EP0979233A1 Method for solution phase synthesis of oligonucleotides |
| 02/16/2000 | EP0691948B1 Protecting group for use in oligodeoxyribonucleotide synthesis |
| 02/16/2000 | CN1244533A Zinc scutellarin as a new medicine |
| 02/15/2000 | US6025505 Fluorescent labeling probes for immunoassays, dna sequencing, detecting products of polymerase chain reactions |
| 02/15/2000 | US6025482 Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| 02/15/2000 | US6025343 Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 02/15/2000 | US6025335 L-deoxyribofuranosyl nucleoside phosphodiester dimers where the sugar moiety or at least one of the nucleosides has an l-configuration, cancer and viral infections, in mammals. |
| 02/15/2000 | US6024977 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 02/10/2000 | WO2000006771A2 Nucleic acid labeling compounds |
| 02/10/2000 | WO2000006587A1 New cofactors for methyltransferases |
| 02/10/2000 | WO2000006177A1 Autoinducer synthase modulating compounds and uses therefor |
| 02/10/2000 | WO2000006174A1 Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | WO1999061012A3 Therapeutic dinucleotide and derivatives |
| 02/10/2000 | WO1999023104A3 Antitumour uridine analogues |
| 02/10/2000 | CA2339016A1 Nucleic acid labeling compounds |
| 02/10/2000 | CA2337710A1 Autoinducer synthase modulating compounds and uses therefor |
| 02/09/2000 | EP0977767A1 Aminooxy-modified oligonucleotides |
| 02/09/2000 | EP0977763A1 Protected aminosugars |
| 02/08/2000 | US6022964 Spiroadamantyl dioxetanes with an alkoxy substituent and a naphthyl substituent on the dioxetane ring which can be activated by enzymatic cleavage of labile group; kinetics and signal intensity depends on electron-activating group |
| 02/08/2000 | US6022963 Synthesis of oligonucleotide arrays using photocleavable protecting groups |
| 02/08/2000 | US6022527 Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof |
| 02/08/2000 | US6022311 Apparatus and method for a custom soft-solid hearing aid |
| 02/08/2000 | CA2006387C Xanthine derivatives with adenosine-antagonistic activity |
| 02/03/2000 | WO2000004866A2 Preparation of thioarabinofuranosyl compounds and use thereof |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999050251A3 Cyclin dependent kinase inhibitors |
| 02/02/2000 | EP0975373A1 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents |
| 02/01/2000 | US6020483 Nucleoside modifications by palladium catalyzed methods |
| 02/01/2000 | US6020482 Phosphotriester type biologically active compounds |
| 02/01/2000 | US6020481 Fluorescent labeling reagents; dideoxy polynucleotide sequencing and fragment analysis methods. |
| 02/01/2000 | US6020480 Caged NADP and NAD |
| 02/01/2000 | US6020322 Acyl deoxyribonucleoside derivatives and uses thereof |
| 02/01/2000 | US6020320 Acyl deoxyribonucleoside derivatives and uses thereof |
| 01/27/2000 | WO2000004036A1 Photocleavable nucleoside base |
| 01/27/2000 | WO2000004034A2 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/27/2000 | WO2000004007A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/26/2000 | EP0973938A1 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973788A1 Tricyclic base analogues |
| 01/26/2000 | CN1242373A Novel arabinosyladenine derivatives |
| 01/25/2000 | CA2163904C Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 01/20/2000 | WO2000002895A1 Arylsulfone linkers for mass spectrometric analysis |
| 01/20/2000 | WO2000002892A1 Novel antibacterial compounds |
| 01/20/2000 | CA2385987A1 Arylsulfone linkers for mass spectrometric analysis |
| 01/19/2000 | EP0971717A1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
| 01/19/2000 | CN1048495C Tetrahydropyran derivatives, its producing process and their medical composition containing them |
| 01/19/2000 | CN1048493C O6-substituted guanine derivatives, a process for their prepn. and their use |
| 01/18/2000 | US6015895 Linker arm for solid support oligonucleotide synthesis and process for production thereof |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO1999052923A3 Method for the production of pentopyranosyl nucleosides |
| 01/13/2000 | WO1998049177A8 Anti-viral pyrimidine nucleoside analogues |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/12/2000 | EP0970101A2 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
| 01/12/2000 | EP0970100A1 Benzimidazole derivatives |
| 01/12/2000 | EP0969822A2 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 01/11/2000 | USRE36494 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| 01/11/2000 | US6013790 Heavily fluorinated sugar analogs |
| 01/11/2000 | US6013785 Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages |
| 01/11/2000 | US6013434 For polymerase chain reaction primers or substrates for dna or rna polymerase |
| 01/06/2000 | WO2000000501A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 01/06/2000 | WO2000000499A1 Method for preparing oligonucleotides with boranophosphate linkages |
| 01/06/2000 | WO1998034942A3 Dinucleotides and their use |
| 01/06/2000 | CA2336285A1 Aryl phosphate derivatives of d4t having anti-hiv activity |
| 01/05/2000 | EP0968223A1 Bioconjugation of macromolecules |
| 01/04/2000 | US6011143 Artificial nucleic acids and a method of making |
| 01/04/2000 | US6011020 Nucleic acid ligand complexes |
| 01/04/2000 | US6011018 Regulated transcription of targeted genes and other biological events |
| 12/29/1999 | WO1999067266A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 12/29/1999 | WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 12/29/1999 | WO1999067264A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 12/29/1999 | WO1999067263A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 12/29/1999 | WO1999067262A1 Adenosine derivatives |
| 12/29/1999 | EP0967220A1 Novel arabinosyladenine derivatives |
| 12/29/1999 | EP0967219A1 Compounds having energy transfer function and method for dna base sequencing by using the same |